These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19663674)

  • 21. Pharmacogenomics of essential hypertension: are we going the right way?
    Filigheddu F; Troffa C; Glorioso N
    Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):7-15. PubMed ID: 16529546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension pharmacogenomics: in search of personalized treatment approaches.
    Cooper-DeHoff RM; Johnson JA
    Nat Rev Nephrol; 2016 Feb; 12(2):110-22. PubMed ID: 26592190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using genotyping to predict responses to anti-hypertensive treatment.
    Kurland L; Lind L; Melhus H
    Trends Pharmacol Sci; 2005 Sep; 26(9):443-7. PubMed ID: 16055200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenomics of hypertension.
    Cadman PE; O'Connor DT
    Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):61-70. PubMed ID: 12496668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomics of hypertension and heart disease.
    Arwood MJ; Cavallari LH; Duarte JD
    Curr Hypertens Rep; 2015 Sep; 17(9):586. PubMed ID: 26272307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A hypertension gene: are we there yet?
    Lupton SJ; Chiu CL; Lind JM
    Twin Res Hum Genet; 2011 Aug; 14(4):295-304. PubMed ID: 21787111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Pharmacogenomics of Anti-Hypertensive Therapy.
    Padmanabhan S; Paul L; Dominczak AF
    Pharmaceuticals (Basel); 2010 Jun; 3(6):1779-1791. PubMed ID: 27713329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenomics of Antihypertensive Drugs in Brazil: Recent Progress and Clinical Implications.
    Vecchia Genvigir FD; Dagli-Hernandez C; Hirata TDC; Zhou Y; Lauschke VM; Hirata MH; Hirata RDC
    Endocr Metab Immune Disord Drug Targets; 2022; 22(13):1263-1275. PubMed ID: 34951375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-gene interactions between genetic polymorphisms and antihypertensive therapy.
    Schelleman H; Stricker BH; De Boer A; Kroon AA; Verschuren MW; Van Duijn CM; Psaty BM; Klungel OH
    Drugs; 2004; 64(16):1801-16. PubMed ID: 15301563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomics of Hypertension Treatment.
    Rysz J; Franczyk B; Rysz-Górzyńska M; Gluba-Brzózka A
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacogenetics--pathway to individualized antihypertensive pharmacotherapy].
    Kurland L; Lind L; Lithell H; Syvänen AC; Melhus H
    Lakartidningen; 2003 Feb; 100(8):600-3. PubMed ID: 12640971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension pharmacogenomics: current status and future directions.
    Johnson JA; Turner ST
    Curr Opin Mol Ther; 2005 Jun; 7(3):218-25. PubMed ID: 15977418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genes and hypertension.
    Garcia EA; Newhouse S; Caulfield MJ; Munroe PB
    Curr Pharm Des; 2003; 9(21):1679-89. PubMed ID: 12871201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics and other reasons why drugs can fail in pregnancy: higher dose or different drug?
    Haas DM; DʼAlton M
    Obstet Gynecol; 2012 Nov; 120(5):1176-9. PubMed ID: 23090536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenomics of blood pressure response to antihypertensive treatment.
    Mellen PB; Herrington DM
    J Hypertens; 2005 Jul; 23(7):1311-25. PubMed ID: 15942450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response.
    Liljedahl U; Karlsson J; Melhus H; Kurland L; Lindersson M; Kahan T; Nyström F; Lind L; Syvänen AC
    Pharmacogenetics; 2003 Jan; 13(1):7-17. PubMed ID: 12544508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene-environment interactions of selected pharmacogenes in arterial hypertension.
    Bochud M; Guessous I
    Expert Rev Clin Pharmacol; 2012 Nov; 5(6):677-86. PubMed ID: 23234325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.
    Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
    JAMA; 2008 Jan; 299(3):296-307. PubMed ID: 18212314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human pharmacogenomic variation of antihypertensive drugs: from population genetics to personalized medicine.
    Polimanti R; Iorio A; Piacentini S; Manfellotto D; Fuciarelli M
    Pharmacogenomics; 2014 Feb; 15(2):157-67. PubMed ID: 24444406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.